Nachrichten zur Fate Therapeutics Aktie

FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ: FATE)

NEW YORK, Feb. 15, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fate Therapeutics,…

FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders

NEW YORK, Feb. 14, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - FATE

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…

DEADLINE ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 22, 2023 in Fate Lawsuit - FATE

New York, New York--(Newsfile Corp. - February 13, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Attention Fate Therapeutics, Inc. ("Fate") (NASDAQ: FATE) shareholders: The Law Offices of Vincent…

ALERT: Investors in Fate Therapeutics, Inc. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FATE

San Diego, California--(Newsfile Corp. - February 10, 2023) - The law firm of Robbins Geller Rudman & Dowd LLP announces…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE

New York, New York--(Newsfile Corp. - February 10, 2023) - Pomerantz LLP announces that a class action lawsuit has been…

FATE SHAREHOLDER ALERT: Jakubowitz Law Reminds Fate Shareholders of a Lead Plaintiff Deadline of March 22, 2023

NEW YORK, Feb. 10, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on…

FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

New York, New York--(Newsfile Corp. - February 9, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…

FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Feb. 9, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (FATE)

New York, New York--(Newsfile Corp. - February 8, 2023) - The securities litigation law firm of The Gross Law Firm…

SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ: FATE)

NEW YORK, Feb. 8, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fate Therapeutics,…

FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders

NEW YORK, Feb. 7, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE

NEW YORK, Feb. 7, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…

FATE Investors Have Opportunity to Lead Fate Therapeutics, Inc. Securities Fraud Lawsuit

BENSALEM, Pa., Feb. 6, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have…

ROSEN, A LONGSTANDING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE

NEW YORK, Feb. 5, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE

New York, New York--(Newsfile Corp. - February 3, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE

New York, New York--(Newsfile Corp. - February 2, 2023) - Pomerantz LLP announces that a class action lawsuit has been…

FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Feb. 2, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…

Bronstein, Gewirtz & Grossman, LLC Notifies Fate Therapeutics, Inc. (FATE) Investors of Class Action and to Actively Participate

NEW YORK, Feb. 1, 2023 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class…

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 31, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…

FATE ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of March 22, 2023 in the Class Action Filed on Behalf of Fate Therapeutics, Inc. Shareholders

NEW YORK, Jan. 31, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed…

ROSEN, A LEADING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - FATE

NEW YORK, Jan. 30, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of…

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 30, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…

CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Fate Investors of a Lead Plaintiff Deadline of March 22, 2023

NEW YORK, Jan. 30, 2023 /PRNewswire/ -- Attention Fate Therapeutics, Inc. ("Fate") (NASDAQ: FATE) shareholders: The Law Offices of Vincent…

INVESTOR NOTICE: Fate Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FATE

SAN DIEGO, Jan. 28, 2023 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Fate…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE

NEW YORK, Jan. 27, 2023 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against certain…

ROSEN, A LEADING LAW FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATE

New York, New York--(Newsfile Corp. - January 27, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, announces…

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 26, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…

FATE LAWSUIT ALERT: Levi & Korsinsky Notifies Fate Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Jan. 26, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc. ("Fate" or the…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fate Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline - FATE

New York, New York--(Newsfile Corp. - January 25, 2023) - Pomerantz LLP announces that a class action lawsuit has been…

INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 25, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…

INVESTOR DEADLINE: Fate Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FATE

San Diego, California--(Newsfile Corp. - January 24, 2023) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers…

ROSEN, A LEADING AND RANKED FIRM, Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - FATE

NEW YORK, Jan. 24, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing…

Fate Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before March 22, 2023 to Discuss Your Rights - FATE

New York, New York--(Newsfile Corp. - January 24, 2023) - Levi & Korsinsky, LLP notifies investors in Fate Therapeutics, Inc.…

INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 24, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 23, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds…

Fate Therapeutics Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information

Boston, Massachusetts--(Newsfile Corp. - January 23, 2023) - Block & Leviton announces that a class action lawsuit has been filed…

Fate Therapeutics Shareholder Class Action Investigation: Submit Your Losses to Johnson Fistel

FATE Class Action Investigation has Commenced on Behalf of ShareholdersSan Diego, California--(Newsfile Corp. - January 21, 2023) - Shareholder rights…

ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Fate Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 19, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…

Fate Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - January 17, 2023) - Block & Leviton is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) for…

Insiderhandel: Aufsichtsrat kauft Aktien von Fate Therapeutics im Wert von 499.232$

Mendlein, John - Aufsichtsrat - Tag der Transaktion: 2023-01-11...…

Insiderhandel: Aufsichtsrat kauft Aktien von Fate Therapeutics im Wert von 198.906$

Mendlein, John - Aufsichtsrat - Tag der Transaktion: 2023-01-13...…

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Fate Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 12, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…

Insiderhandel: Chief Medical Officer verkauft Aktien von Fate Therapeutics im Wert von 41.003$

Chu, Yu-Waye - Vorstand - Tag der Transaktion: 2023-01-10...…

Insiderhandel: Chief Technical Officer verkauft Aktien von Fate Therapeutics im Wert von 17.910$

Plavsic, Mark - Vorstand - Tag der Transaktion: 2023-01-10...…

Fate Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the Firm

Boston, Massachusetts--(Newsfile Corp. - January 11, 2023) - Block & Leviton is investigating Fate Therapeutics, Inc. (NASDAQ: FATE) for…

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Fate Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

Los Angeles, California--(Newsfile Corp. - January 11, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces…